Get started
RocketTickers

Marker Therapeutics Receives FDA Orphan Drug Designation for its

Long
Marker Therapeutics, Inc. (NASDAQ:MRKR)  
RocketTickers  
NASDAQ:MRKR   Marker Therapeutics, Inc.
Beyond Technical Analysis
5
0
beyondta
MRKR: Marker Therapeutics, Inc.
2020-04-29 16:05:00
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.